- Home
- ISTR vs CMPX Comparison
ISTR vs CMPX Comparison
Compare ISTR & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISTR
- CMPX
- Stock Information
- Founded
- ISTR 2006
- CMPX 2014
- Country
- ISTR United States
- CMPX United States
- Employees
- ISTR N/A
- CMPX N/A
- Industry
- ISTR Major Banks
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- ISTR Finance
- CMPX Health Care
- Exchange
- ISTR Nasdaq
- CMPX Nasdaq
- Market Cap
- ISTR 189.6M
- CMPX 291.8M
- IPO Year
- ISTR 2014
- CMPX N/A
- Fundamental
- Price
- ISTR $21.87
- CMPX $2.65
- Analyst Decision
- ISTR Buy
- CMPX Strong Buy
- Analyst Count
- ISTR 1
- CMPX 9
- Target Price
- ISTR $27.00
- CMPX $12.67
- AVG Volume (30 Days)
- ISTR 46.5K
- CMPX 816.0K
- Earning Date
- ISTR 07-21-2025
- CMPX 08-11-2025
- Dividend Yield
- ISTR 1.89%
- CMPX N/A
- EPS Growth
- ISTR 22.25
- CMPX N/A
- EPS
- ISTR 2.19
- CMPX N/A
- Revenue
- ISTR $88,885,000.00
- CMPX $850,000.00
- Revenue This Year
- ISTR $2.04
- CMPX N/A
- Revenue Next Year
- ISTR $9.79
- CMPX N/A
- P/E Ratio
- ISTR $10.04
- CMPX N/A
- Revenue Growth
- ISTR 6.35
- CMPX N/A
- 52 Week Low
- ISTR $15.39
- CMPX $0.87
- 52 Week High
- ISTR $24.81
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- ISTR 70.31
- CMPX 64.52
- Support Level
- ISTR $21.97
- CMPX $2.62
- Resistance Level
- ISTR $22.46
- CMPX $2.87
- Average True Range (ATR)
- ISTR 0.68
- CMPX 0.16
- MACD
- ISTR 0.32
- CMPX 0.00
- Stochastic Oscillator
- ISTR 90.89
- CMPX 81.03
About ISTR Investar Holding Corporation
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.